锦欣生殖医疗集团有限公司（01951）于2026年8月28日发布公告，披露当日在香港联交所场内回购股份事宜。公司此次共回购1,321,500股普通股，约占回购前已发行股本的0.0489%。每股回购价格介乎每股2.25港元至2.32港元，总交易金额为约299.99万港元。
公告显示，截至本次回购完成后，公司已发行股本为2,701,059,043股，并持有库藏股3,985,000股，总股份数为2,705,044,043股。公司于2026年6月25日通过了购回授权，最多可回购约2.63亿股。截至目前，公司已根据该授权累计回购16,526,500股，约占授权通过当日已发行股本的0.6296%，剩余可回购数量约为2.46亿股。
公司确认已遵守香港联合交易所有限公司证券上市规则及有关回购股份的适用法例。公告由公司董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.